SLN · Silence Therapeutics plc

$13.72 -0.25 (-1.79%) At close · Aug 14

Market Cap

$1.94B

141.74M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-08-12	2026-08-10
8-K	2026-08-10	—
8-K	2026-08-10	—
10-Q	2026-08-10	2026-06-30
8-K/A	2026-07-16	2026-07-10
Investor Event Transcript	2026-06-30	—
8-K	2026-06-23	—
8-K	2026-06-16	—
8-K	2026-06-11	—
Investor Event Transcript	2026-06-03	2026-06-30
8-K	2026-05-18	—
10-Q	2026-05-07	2026-03-31
8-K	2026-05-07	—
DEF 14A	2026-04-29	2026-06-16
10-K	2026-03-05	2025-12-31
8-K	2026-03-05	—
8-K/A	2025-12-22	2025-12-14
8-K	2025-12-22	2025-12-18
8-K	2025-12-15	2025-12-14
8-K	2025-11-06	—
10-Q	2025-11-06	2025-09-30
8-K	2025-10-23	—
8-K	2025-08-14	2025-08-11
10-Q	2025-08-07	2025-06-30
8-K	2025-08-07	—
8-K	2025-06-27	2025-06-26
DEF 14A	2025-05-16	2025-06-26
10-Q	2025-05-08	2025-03-31
8-K	2025-05-08	—
8-K	2025-05-06	2025-05-05
10-K/A	2025-04-30	2024-12-31
10-K	2025-02-27	2024-12-31
8-K	2025-02-27	—
8-K	2025-01-02	—
6-K	2024-12-09	—
6-K	2024-11-18	—
6-K	2024-11-14	2024-09-30
6-K	2024-08-15	2024-06-30
6-K	2024-06-27	—
6-K	2024-06-24	—
6-K	2024-06-20	—
6-K	2024-05-17	—
6-K	2024-05-16	2024-03-31
6-K	2024-05-01	—
6-K	2024-04-29	—
6-K	2024-04-15	—
6-K	2024-03-13	—
20-F	2024-03-13	2023-12-31
6-K	2024-02-23	—
6-K	2024-02-06	2024-02-05

Showing 1–50 of 105 filings

Key facts CIK 1479615 CUSIP 82686Q101 13F (30d) 73 filings 72 filers Visit website Investor relations